Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • IYR vs GSK✓SelectedUSD · GSKIYR vs GSK performance historyLatest closeAs of-0.87%11/20
Stock and ETF performance explorer

IYR vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+2.5%
GSK return
+40.7%
Excess return
-38.1%
Maximum drawdown
-33.7%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 5y.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D-0.9%-0.1%-0.7%-0.8%
7D-4.1%-5.3%+1.2%-2.8%
30D+1.0%-3.7%+4.7%+1.9%
3M-5.7%-7.3%+1.5%-4.1%
6M-3.1%-4.2%+1.2%-2.3%
YTD+6.0%+0.9%+5.1%+5.2%
1Y+7.3%+7.3%0.0%+4.8%
3Y+28.1%+52.7%-24.6%+11.9%
All+2.5%+40.7%-38.1%-14.8%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 5y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

5y analysis · Full analysis span regression · 6 months rolling